Shares of STERIS plc (STE) plummeted 6.37% on Wednesday, November 7, despite the company reporting better-than-expected earnings for the second quarter of fiscal 2025. The stock's decline suggests that investors were concerned about margin pressure and weaker-than-anticipated revenue growth.
The medical equipment and services provider reported adjusted earnings per share of $2.14, surpassing the consensus estimate of $2.12 and representing a 15.1% increase from the year-ago quarter. However, revenues of $1.33 billion fell slightly short of analysts' expectations of $1.33 billion, rising 7.3% year-over-year.
A key factor contributing to STERIS's stock price decline was the contraction in gross margin, which fell 56 basis points to 43.6% due to an 8.4% increase in the cost of revenues. The company's adjusted operating margin expanded by 127 basis points to 16.7%, but this improvement was not enough to alleviate investors' concerns about profitability pressures.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。